Commure’s latest acquisition sends follow-up texts to patients

General Catalyst-backed Commure is buying another General Catalyst-backed startup that sends follow-up texts to patients.

Commure, which was valued at over …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Q&A with Obesity Society’s CEO as the field prepares for next-gen meds

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

November 2, 2024

Veeva Commercial Summit: Increased investment in medical affairs by pharma companies

Veeva’s VP of global medical, Christoph Bug, stated that Veeva has also invested in medical affairs. Image credit: Veeva. Pharmaceutical companies are always looking to

November 20, 2024

FDA finalizes opioid safety labeling changes

The FDA late Friday finalized new requirements for safety labeling on new opioid pain medications, marking progress in the agency’s effort to crack down on

December 19, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.